Cargando…
Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease
AIM: To evaluate risk factors for primary sclerosing cholangitis (PSC) recurrence (rPSC) after orthotopic liver transplantation (OLT) in patients with well-preserved colons. METHODS: We retrospectively evaluated the medical records of all patients transplanted for PSC in our center between July 1994...
Autores principales: | Bajer, Lukas, Slavcev, Antonij, Macinga, Peter, Sticova, Eva, Brezina, Jan, Roder, Matej, Janousek, Radim, Trunecka, Pavel, Spicak, Julius, Drastich, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250922/ https://www.ncbi.nlm.nih.gov/pubmed/30487703 http://dx.doi.org/10.3748/wjg.v24.i43.4939 |
Ejemplares similares
-
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
por: Bajer, Lukas, et al.
Publicado: (2017) -
Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
por: Brezina, Jan, et al.
Publicado: (2022) -
Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass
por: Macinga, Peter, et al.
Publicado: (2017) -
A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review
por: Fabian, Ondrej, et al.
Publicado: (2023) -
Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial
por: Březina, Jan, et al.
Publicado: (2021)